The National Pharmaceutical Pricing Authority has finalised the ceiling prices of 97 scheduled formulations and approved revised ceiling prices of 31 formulations that are a part of the National List of Essential Medicines.
Under the revised Schedule I of the Drugs (Prices Control) Order, or DPCO, the NPPA notified the calculation and the maximum ceiling limit for prices that could be charged for listed essential medicines, according to the release issued on Jan. 6.
According to Professor Bejon Kumar Misra, Founder at Patient Safety and Access Initiative of India Foundation, in the area of public health, harm reduction is about developing policies to try and minimise the negative health impact of a risky activity without stopping it entirely.Most
The Indian government must try to reduce tobacco use and second-hand smoke by adopting a robust consumer awareness movement regarding the harms caused by tobacco use, a top international consumer policy expert said on Friday.According to .
The Court observed that if policy to make cancer medicine affordable is not promulgated, majority of the country's population will be vulnerable to the disease given the unaffordability
A market study of the Competition Commission of India (CCI) on the pharmaceutical industry revealed that from August 2019 to July 2020, as many as 2,871 formulations were being sold under 47,478 brands. On an average, there were as many as 17 brands for one formulation. Competition usually brings do